A pharmacokinetic comparison of orally inhaled budesonidedelivered via SkyePharma HFA metered dose inhaler and marketed CFC metered dose inhaler (Pulmicort , AstraZeneca) in healthy male and female volunteers.

Study identifier:D5252C00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A pharmacokinetic comparison of orally inhaled budesonidedelivered via SkyePharma HFA metered dose inhaler and marketed CFC metered dose inhaler (Pulmicort , AstraZeneca) in healthy male and female volunteers.

Medical condition

asthma

Phase

Phase 1

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jun 2002
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria